FindTrial
Sign In

Expression of E6 and E7 among precancerous and cancerous lesions cervix

To determine the expression of E6 and E7 in precancerous and cancerous lesions of cervix by using Immuno-histochemistry: An Observational Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/077500
Enrollment
31
Registered
2024-11-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Control Intervention1: NIL: NIL

Sponsors

AIIMS Bathinda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with age more than 18 years 2. Patients with precancerous and cancerous lesions of cervix 3.Patients who have given their consent.

Exclusion criteria

Exclusion criteria: 1. Patients with age less than 18 years 2. Inadequate/Non representative sampling 3. Non neoplastic lesions on histopathology

Design outcomes

Primary

MeasureTime frame
Expression of E6 and E7 on preoperative cervical biopsyTimepoint: At baseline—

Secondary

MeasureTime frame
Expression of p16 in preoperative cervical biopsy & comparison with E6 & E7 expressionTimepoint: At Baseline—

Countries

India

Contacts

Public ContactDr Vidushi joshi

AIIMS Bathinda

drmrsmanjitkaur@gmail.com8427950069

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026